Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Come Lepage"'
Autor:
Julie Lecuelle, Caroline Truntzer, Debora Basile, Luigi Laghi, Luana Greco, Alis Ilie, David Rageot, Jean-François Emile, Fréderic Bibeau, Julien Taïeb, Valentin Derangere, Come Lepage, François Ghiringhelli
Publikováno v:
EBioMedicine, Vol 105, Iss , Pp 105207- (2024)
Summary: Background: T-cell immune infiltrates are robust prognostic variables in localised colon cancer. Evaluation of prognosis using artificial intelligence is an emerging field. We evaluated whether machine learning analysis improved prediction o
Externí odkaz:
https://doaj.org/article/f4866831da2d49b389ebad9f61f0d2b7
Autor:
Sylvain Manfredi, Marie Dior, Olivier Bouche, Emilie Barbier, Vincent Hautefeuille, Marielle Guillet, Justine Turpin, Vincent Bourgeois, Dall Osto Helene, Romain Desgrippes, Franck Audemar, Yann Molin, Christophe Locher, Thierry Chatellier, Thierry Lecomte, Nathalie Baize, Cedric Lecaille, Dominique Spaeth, Gael Goujon, Come Lepage, David Tougeron, For The Metestomac Investigators/Collaborators
Publikováno v:
Cancer Medicine, Vol 12, Iss 5, Pp 5341-5351 (2023)
Abstract Background Around 50% of gastric cancers are diagnosed at an advanced stage. Several chemotherapy regimens are now internationally validated. Few data are available on the routine daily management of advanced gastric or gastroesophageal junc
Externí odkaz:
https://doaj.org/article/c63cf54191d040b09637705899990774
Autor:
Camille Evrard, Thomas Aparicio, Emilie Soularue, Karine Le Malicot, Jérôme Desramé, Damien Botsen, Farid El Hajbi, Daniel Gonzalez, Come Lepage, Olivier Bouché, David Tougeron, on behalf of the DURIGAST—PRODIGE 59 Investigators/Collaborators
Publikováno v:
Biomedicines, Vol 10, Iss 5, p 1211 (2022)
Efficacy of immune checkpoint inhibitors (ICI) as monotherapy in 2nd line treatment for gastric or gastro-oesophageal junction (GEJ) adenocarcinoma is low, with no evaluation of efficacy and safety of ICI combined with chemotherapy. The DURIGAST PROD
Externí odkaz:
https://doaj.org/article/e5f33636db76484d82559bf48a274df7
Autor:
Come Lepage, Harry Sokol, Julien Taieb, Thierry Lecomte, Vincent Hautefeuille, Romain Coriat, David Tougeron, Laétitia Dahan, Pierre Laurent-Puig, Jean Francois Emile, Stephano Kim, Carole Monterymard, Marine Gilabert, BEZ Jérémie, Astrid Lievre, Laurent Mineur, Jean Louis Legoux, Jean marc Phelip, Claude Capron, Claire Gallois, Violaine Randrian
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/d3740235834540abbdaef133b6721c3f
Autor:
Manon Réda, Corentin Richard, Aurelie Bertaut, Julie Niogret, Thomas Collot, Jean David Fumet, Julie Blanc, Caroline Truntzer, Isabelle Desmoulins, Sylvain Ladoire, Audrey Hennequin, Laure Favier, Leila Bengrine, Julie Vincent, Alice Hervieu, Jean-Florian Guion Dusserre, Come Lepage, Pascal Foucher, Christophe Borg, Juliette Albuisson, Laurent Arnould, Sophie Nambot, Laurence Faivre, Romain Boidot, Francois Ghiringhelli
Publikováno v:
EBioMedicine, Vol 51, Iss , Pp - (2020)
Background: Genomically-guided clinical trials are performed across different tumor types sharing genetic mutations, but trial organization remains complex. Here we address the feasibility and utility of routine somatic and constitutional exome analy
Externí odkaz:
https://doaj.org/article/e28bb1596617481991af99f2ee075d39
Autor:
Delphine Salfati, Margaux Huot, Thomas Aparicio, Come Lepage, Julien Taieb, Olivier Bouché, Valérie Boige, Jean-Marc Phelip, Laetitia Dahan, Jaafar Bennouna, Karine Le Malicot, Olayide Boussari, Jean-Marc Gornet
Publikováno v:
Digestive and Liver Disease. 55:791-798
Autor:
David Piquemal, Roman Bruno, Barbara Bournet, Francois Ghiringhelli, Florian Noguier, Cindy Canivet, Aurélie Bertaut, Fabien Pierrat, Ludovic Evesque, Amelia Gamez, Jerome Cros, Emilie Rederstorff, Erwan Petit, Johan Adnet, Angélique Saint, Antoine Drouillard, Emmanuelle Kempf, Emilie Soularue, Julie Vincent, Isabelle Baumgaertner, Audrey Hennequin, Christophe Tournigand, Daniel Lopez Trabada Ataz, Leila Bengrine, Come Lepage, Sylvain Manfredi, Pauline Afchain, Isabelle Trouilloud, Alice Gagnaire, Noelle K. LoConte, Jean-Baptiste Bachet
Publikováno v:
Journal of Gastrointestinal Oncology. 14:997-1007
Autor:
Caroline Gronnier, Christophe Mariette, Come Lepage, Carole Monterymard, Marine Jary, Aurélie Ferru, Mathieu Baconnier, Xavier Adhoute, David Tavan, Hervé Perrier, Véronique Guerin-Meyer, Cédric Lecaille, Nathalie Bonichon-Lamichhane, Didier Pillon, Oana Cojocarasu, Joëlle Egreteau, Xavier Benoit D’journo, Laétitia Dahan, Christophe Locher, Patrick Texereau, Denis Collet, Pierre Michel, Meher Ben Abdelghani, Rosine Guimbaud, Marie Muller, Olivier Bouché, Guillaume Piessen
Publikováno v:
Cancers; Volume 15; Issue 7; Pages: 2188
Purpose: While perioperative chemotherapy provides a survival benefit over surgery alone in gastric and gastroesophageal junction (G/GEJ) adenocarcinomas, the results need to be improved. This study aimed to evaluate the efficacy and safety of periop
Autor:
Simon Pernot, Olivier Pellerin, Laurent Mineur, Carole Monterymard, Denis Smith, Bruno Lapuyade, Claire Gallois, Faiza Khemissa Akouz, Thierry De Baere, David Tougeron, Anne Thirot-Bidault, Franck Audemar, Mireille Simon, Cedric Lecaille, Sami Louafi, Come Lepage, Michel Ducreux, Julien Taieb
Publikováno v:
Digestive and Liver Disease. 54:324-330
In patients with unresectable liver metastases from colorectal cancer (CRCLM), systemic doublet or triplet chemotherapy and targeted therapy is considered a standard first-line treatment. Hepatic arterial infusion of oxaliplatin (HAI-ox) generates a
Autor:
Sylvain, Manfredi, Marie, Dior, Olivier, Bouche, Emilie, Barbier, Vincent, Hautefeuille, Marielle, Guillet, Justine, Turpin, Vincent, Bourgeois, Dall Osto, Helene, Romain, Desgrippes, Franck, Audemar, Yann, Molin, Christophe, Locher, Thierry, Chatellier, Thierry, Lecomte, Nathalie, Baize, Cedric, Lecaille, Dominique, Spaeth, Gael, Goujon, Come, Lepage, David, Tougeron
Publikováno v:
Cancer medicineREFERENCES.
Around 50% of gastric cancers are diagnosed at an advanced stage. Several chemotherapy regimens are now internationally validated. Few data are available on the routine daily management of advanced gastric or gastroesophageal junction cancers. We aim